Year-End Report

WINNING STRATEGIES WASHINGTON for GENENTECH INC (FORMERLY KNOWN AS HOFFMAN-LA ROCHE INC)

Firm
Client
Income
$100,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Early Treatment for HIV Act Legislation on public health preparedness and response related to pandemic influenza S.1445 and H.R. 2552, Senate and House versions of the Hepatitis C Epidemic Control and Prevention Act. Influenza Pandemic Preparedness federal, state and local levels

LobbyistCovered position, as disclosed
ALEX DELPIZZO N/A
MICHAEL A MEROLA N/A
DONNA MULLINS N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1445 (110th), H.R. 2552 (110th)

Budget/Appropriations BUD

H.R. 3043; S.1710-Labor, HHS and Education Appropriations related to preparedness for pandemic influenza, HIV/AIDS programs and HCV screening, care and treatment

LobbyistCovered position, as disclosed
ALEX DELPIZZO N/A
MICHAEL A MEROLA N/A
DONNA MULLINS N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3043 (110th), S. 1710 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.